Today's Pre-Open Stock MoversProteon Therapeutics, Inc. (Nasdaq: PRTO) 40% HIGHER; announced that its investigational treatment, vonapanitase, has received Breakthrough Therapy ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)